作者: Nobutaka Ninomiya , Chisato Makino , Haruo Orita , Hidetoshi Sakai , Shigeru Shioya
DOI:
关键词: Nateglinide 、 Endocrinology 、 Internal medicine 、 Normal level 、 Oral administration 、 Medicine 、 Antidiabetic preparation 、 Fasting blood glucose level 、 Controlled release drug 、 Drug 、 Post prandial blood glucose
摘要: There is provided a single preparation which directly decreases both of the post prandial blood glucose level and fasting close to normal levels, by release-sustaining drug capable decreasing diabetic patients level, or mixing controlled release with an immediate drug. It particularly preferable that nateglinide.